These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 26945573)

  • 1. The value of serum RASSF10 hypermethylation as a diagnostic and prognostic tool for gastric cancer.
    Xue WJ; Feng Y; Wang F; Li P; Liu YF; Guo YB; Wang ZW; Mao QS
    Tumour Biol; 2016 Aug; 37(8):11249-57. PubMed ID: 26945573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ras association domain family member 10 suppresses gastric cancer growth by cooperating with GSTP1 to regulate JNK/c-Jun/AP-1 pathway.
    Li X; Liang Q; Liu W; Zhang N; Xu L; Zhang X; Zhang J; Sung JJ; Yu J
    Oncogene; 2016 May; 35(19):2453-64. PubMed ID: 26279301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of the serum
    Hu Y; Ma P; Feng Y; Li P; Wang H; Guo Y; Mao Q; Xue W
    J Int Med Res; 2019 Jul; 47(7):2890-2900. PubMed ID: 31119967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RASSF10 is an epigenetically silenced tumor suppressor in gastric cancer.
    Li Z; Chang X; Dai D; Deng P; Sun Q
    Oncol Rep; 2014 Apr; 31(4):1661-8. PubMed ID: 24573726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation status of TRAF2 is associated with the diagnosis and prognosis of gastric cancer.
    Zhang J; Dai WJ; Yang XZ
    Int J Clin Exp Pathol; 2015; 8(11):14228-34. PubMed ID: 26823737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.
    Balgkouranidou I; Matthaios D; Karayiannakis A; Bolanaki H; Michailidis P; Xenidis N; Amarantidis K; Chelis L; Trypsianis G; Chatzaki E; Lianidou ES; Kakolyris S
    Mutat Res; 2015 Aug; 778():46-51. PubMed ID: 26073472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum angiopoietin-like protein 2 as a potential biomarker for diagnosis, early recurrence and prognosis in gastric cancer patients.
    Toiyama Y; Tanaka K; Kitajima T; Shimura T; Imaoka H; Mori K; Okigami M; Yasuda H; Okugawa Y; Saigusa S; Ohi M; Inoue Y; Mohri Y; Goel A; Kusunoki M
    Carcinogenesis; 2015 Dec; 36(12):1474-83. PubMed ID: 26420253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma.
    Wang F; Feng Y; Li P; Wang K; Feng L; Liu YF; Huang H; Guo YB; Mao QS; Xue WJ
    Oncotarget; 2016 Jan; 7(4):4279-97. PubMed ID: 26701853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zic1 Promoter Hypermethylation in Plasma DNA Is a Potential Biomarker for Gastric Cancer and Intraepithelial Neoplasia.
    Chen X; Lin Z; Xue M; Si J; Chen S
    PLoS One; 2015; 10(7):e0133906. PubMed ID: 26207911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA hypermethylation of tumor suppressor genes RASSF6 and RASSF10 as independent prognostic factors in adult acute lymphoblastic leukemia.
    Younesian S; Shahkarami S; Ghaffari P; Alizadeh S; Mehrasa R; Ghavamzadeh A; Ghaffari SH
    Leuk Res; 2017 Oct; 61():33-38. PubMed ID: 28869817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LZTS2 promoter hypermethylation: a potential biomarker for the diagnosis and prognosis of laryngeal squamous cell carcinoma.
    Shen Z; Lin L; Cao B; Zhou C; Hao W; Ye D
    World J Surg Oncol; 2018 Mar; 16(1):42. PubMed ID: 29499699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of ASC/TMS1 promoter is associated with poor prognosis of patients with gastric cancer.
    Wu L; Zhang C; Wang X; Ding X; Deng J; Liang H
    Clin Transl Oncol; 2016 Mar; 18(3):296-303. PubMed ID: 26260914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic Silencing of the MLH1 Promoter in Relation to the Development of Gastric Cancer and its use as a Biomarker for Patients with Microsatellite Instability: a Systematic Analysis.
    Hu G; Qin L; Zhang X; Ye G; Huang T
    Cell Physiol Biochem; 2018; 45(1):148-162. PubMed ID: 29334683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of expression and methylation status of DENN/MADD domain-containing protein 2D in gastric cancer.
    Kanda M; Shimizu D; Nomoto S; Takami H; Hibino S; Oya H; Hashimoto R; Suenaga M; Inokawa Y; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Gastric Cancer; 2015 Apr; 18(2):288-96. PubMed ID: 24695972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual methylation of tumor suppressor gene promoters, RASSF6 and RASSF10, as novel biomarkers for minimal residual disease detection in adult acute lymphoblastic leukemia.
    Younesian S; Shahkarami S; Ghaffari P; Alizadeh S; Mehrasa R; Ghaffari SH
    Ann Hematol; 2019 Dec; 98(12):2719-2727. PubMed ID: 31486880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnosis value of promoter methylation of UCHL1 in the serum for progression of gastric cancer.
    Wang G; Zhang W; Zhou B; Jin C; Wang Z; Yang Y; Wang Z; Chen Y; Feng X
    Biomed Res Int; 2015; 2015():741030. PubMed ID: 26550574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of ras association domain protein 10 (RASSF10) promoter negative association with the survival of gastric cancer.
    Deng J; Liang H; Ying G; Li H; Xie X; Yu J; Fan D; Hao X
    Am J Cancer Res; 2014; 4(6):916-23. PubMed ID: 25520879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RASSF10 is frequently epigenetically inactivated in kidney cancer and its knockout promotes neoplasia in cancer prone mice.
    Richter AM; Woods ML; Küster MM; Walesch SK; Braun T; Boettger T; Dammann RH
    Oncogene; 2020 Apr; 39(15):3114-3127. PubMed ID: 32047266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation markers and serum α-fetoprotein level are prognostic factors in hepatocellular carcinoma.
    Lin JC; Wu YC; Wu CC; Shih PY; Wang WY; Chien YC
    Ann Hepatol; 2015; 14(4):494-504. PubMed ID: 26019036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the diagnostic and prognostic value of circulating cathepsin S in gastric cancer.
    Liu WL; Liu D; Cheng K; Liu YJ; Xing S; Chi PD; Liu XH; Xue N; Lai YZ; Guo L; Zhang G
    Oncotarget; 2016 May; 7(19):28124-38. PubMed ID: 27058412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.